Filter
622
Filtered Results: 622
Text search:
rapide
confirmation
de
laboratoire
Featured
Recommendations
78
New Publications
164
Language
Document type
No document type
346
Guidelines
136
Studies & Reports
53
Manuals
35
Strategic & Response Plan
31
Fact sheets
9
Training Material
8
Situation Updates
4
Countries / Regions
Congo, Democratic Republic of
49
Senegal
31
Western and Central Europe
26
Africa
19
Eastern Europe
17
Burkina Faso
16
Global
16
Rwanda
15
Guinea
15
Mali
13
Benin
11
Cameroon
11
Latin America and the Carribbean
11
South Africa
11
India
11
Haiti
9
Côte d’Ivoire / Ivory Coast
9
Madagascar
9
Sierra Leone
8
Nigeria
8
West and Central Africa
8
Liberia
8
Niger
7
East and Southern Africa
7
Tanzania
6
Uganda
6
Togo
5
Central African Republic
5
Kenya
4
Ukraine
4
Malawi
4
South–East Asia Region
4
Chad
4
Zimbabwe
3
Western Pacific Region
3
Turkey
2
Ghana
2
Syria
2
Philippines
2
Mozambique
2
Middle East and North Africa
2
France
2
Brazil
2
Namibia
2
Ethiopia
2
Zambia
2
Nepal
1
Colombia
1
Timor Leste/ East Timor
1
Lesotho
1
Estonia
1
Afghanistan
1
Morocco
1
Mauritania
1
Guinea-Bissau
1
Germany
1
Eastern Europe and Central Asia
1
North America
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Argentina
1
Vietnam
1
Yemen
1
Georgia
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
208
Clinical Guidelines
106
Public Health
39
Pharmacy & Technologies
27
Key Resources
21
Women & Child Health
11
Capacity Building
5
Toolboxes
Rapid Response
89
TB
72
COVID-19
69
Ebola & Marburg
55
NTDs
40
HIV
33
Cholera
15
Zika
11
AMR
10
Polio
9
Pharmacy
8
Caregiver
7
Natural Hazards
6
Planetary Health
5
Conflict
5
Mental Health
3
NCDs
3
Specific Hazards
2
Refugee
2
Disability
2
Malaria
2
Global Health Education
1
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
Global HIV Strategic Information Working Group
The following protocol has been designed to investigate the First Few X cases (FFX) and their close contacts. It is envisioned that the FFX 2019-nCoV investigation will be conducted across several countries or sites with geographical and demographical diversity. Using a standardized protocol such a...
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
2nd edition.
Like the original, this second edition of the guidance aims to inform the revision of existing national guidelines and standards for managing Tuberculosis (TB), many of which include guidance on children. It includes recommendations, based on the best available evidence, for improving ...
Buruli ulcer (BU), a neglected tropical disease (NTD), is an infection of the skin and subcutaneous tissue caused by Mycobacterium ulcerans. The disease has been documented in many South American, Asian, and Western Pacific countries and is widespread throughout much of Africa, especially in West...
Frontiers in Pediatrics | www.frontiersin.org
1 April 2019 | Volume 7 | Article 159
A survival guide for clinicans.
3rd edition.
